🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

after a long journey, my meta-analysis on psychedelics is finally published in Translational Psychiatry: doi.org/10.1038/s41398… the paper has changed quite a lot since the first pre-print from over a year ago. 🧵 (1/n)

Great news and yet another significant step forward for psychedelic medicine! Today, atai Life Sciences and Beckley Psytech announced (very!) positive topline results from the long-awaited Phase 2b trial of a single dose of BPL‑003 (5-MeO-DMT) in 193 patients living with

Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH Research's Dosing Model Our notes from this morning's conference call, where company leadership discussed the BPL-003 results and took aim at their closest competitor's model. Read more: psychedelicalpha.com/news/beckley-a…

Yesterday Dr. Amourie Prentice succesfully defended her PhD, join me in congratulating her with a great achievement. Her PhD focused on EEG biomarkers associated with treatment resistance and several chapters that advanced our understanding of Orbitofrontal cortex TMS in

Yesterday, we celebrated the culmination of a remarkable journey with the completion of the 10th Martijn Arns Foundation PhD. This milestone has yielded a wealth of new insights and discoveries that have positively impacted numerous patients worldwide. For access to all the

Andrew D. Huberman, Ph.D. Andrew D. Huberman, Ph.D. what is the best EEG-based model of plasticity that you’re aware of?

Proud to be part of the team!🙏🧠⚡️📚 pubmed.ncbi.nlm.nih.gov/40464151/

Glad to see this published: Trigeminal nerve stimulation as a 'semi-active' TMS control condition: Heart-Brain Coupling identifying 'sham' response to TMS. Implications for power calculation, future meta-analyses and TMS trial design. brainstimjrnl.com/article/S1935-… Great collaboration

Food for thought on the use of the "active" sham in several systems - creative take on the current situation from a great group of thinkers. Trigeminal Nerve Stimulation as a Semi-Active Control Condition in TMS... sciencedirect.com/science/articl…

x.com/i/article/1946…

New infographic on the ability of #TMS to modulate the autonomic nervous system as a mechanism to treat #depression. thanks to Michael Smith Health Research Foundation for their support. researchgate.net/publication/39…

nature.com/articles/s4422…

med.stanford.edu/news/all-news/…

Congrats Neil et al, and another great example of blinded out-of-sample replication using TDBRAIN+ For those interested, access to the large open access TDBRAIN database can be found here: brainclinics.com/resources/tdbr…

One of atai Life Sciences's remaining non–wholly owned programs, inadascamine (RL-007), has shown modest but consistent numerical improvements across the overall MCCB neurocognitive composite in patients with cognitive impairment associated with schizophrenia (CIAS), but didn’t make its

Our paper with Leah Banellis and Micah G. Allen was just published in Nature Mental Health! In a large neuroimaging study (n=243), we show that stronger coupling between the stomach and frontoparietal brain regions predicts poorer mental health

Big news out of Germany this morning! Here's my free-to-read breakdown, including a discussion with the program's key architect Gerhard Gründer...

Great development, compassionate use of Psilocybin for TRD allowed in Germany.